FDA Flags Rare Eye Stroke Risk Linked To Popular GLP-1 Weight-Loss Drugs
US Food and Drug Administration has flagged a potential risk of a rare eye condition, known as non-arteritic anterior ischemic optic neuropathy or eye stroke, linked to popular GLP-1 weight-loss and diabetes medicines. The condition involves reduced blood flow to the optic nerve, causing sudden and often painless loss of vision in one eye, with permanent damage in certain cases. An FDA analysis of 126 clinical trials with over 1.34 lakh participants identified an estimated rate of 6.4 cases per…